Under construction – not a live service
Sign in
WithdrawnNo phase

Imaging of the Esophagus Using a SECM Capsule

Reason given: We are currently working and developing our technology to ensure accurate data collection and safety. We will re-open in the future for recruitment.

Key facts

Where
Boston, United StatesSee the site

Where in United States

  • Massachusetts General HospitalBoston, United StatesNo longer taking part

Trial details

Who runs it
Massachusetts General Hospital
Trial code
NCT03546660
Record updated
22 October 2025
Original description
The goal of this validation study is to compare Spectrally Encoded Confocal Microscopy (SECM) Tethered Capsule Endoscopy (TCE) diagnosis of Eosinophilic Esophagitis to that of standard of care endoscopic biopsy.Read full original descriptionShow less

The goal of this validation study is to compare Spectrally Encoded Confocal Microscopy (SECM) Tethered Capsule Endoscopy (TCE) diagnosis of Eosinophilic Esophagitis to that of standard of care endoscopic biopsy.

Inclusion: Participants 18 years of age or older who are healthy and have no significant health related issues; Participants 14 years of age of older who are undergoing evaluation for EoE; Able to give informed consent or assent as per the age of the subject.

Exclusion: Esophageal fistula and/or esophageal strictures with a stricture diameter that is smaller than the diameter of the capsule; Inability to swallow pills and capsules.

ClinicalTrials.gov NCT03546660